Skip to content
OpenCapital
Get started

NanoViricides NNVC Q4 2025 earnings

Reported February 17, 2026 · After market close

EPS-$0.11Beat by $0.03
EPS estimate-$0.14

Next report

Sep 2, 2026 (in a month)
EPS estimate-$0.10

Versus estimates

Diluted EPS

Q1 2026-$0.09Miss by $0.01
Q4 2025-$0.11Beat by $0.03
Q3 2025-$0.10Beat by $0.08Q2 2025-$0.13Beat by $0.07Q1 2025-$0.14Beat by $0.05Q4 2024-$0.14Beat by $0.04

Ask the moment NanoViricides reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did NanoViricides report Q4 2025 earnings?
NanoViricides (NNVC) reported Q4 2025 earnings on February 17, 2026 after market close.
What were NanoViricides's Q4 2025 revenue and EPS?
NanoViricides reported eps of $-0.11 for Q4 2025.
Did NanoViricides beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.14 by $0.03.
How did NanoViricides's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 21.4% from $-0.14.
Where can I find NanoViricides's Q4 2025 SEC filings?
You can read the 10-Q periodic report (0001104659-26-016476) directly on SEC EDGAR. The filing index links above go to sec.gov.